PYC 1.20% 8.2¢ pyc therapeutics limited

it seems like imyc and omomyc were both sort of orphans in that...

  1. 5,143 Posts.
    lightbulb Created with Sketch. 671
    it seems like imyc and omomyc were both sort of orphans in that rights were owned by ms Soucek or us, and both also required cell penetration tech which would be owned by us.

    Feels like many of these technologies do not interest large pharma unless they can own the whole thing, they "prefer" to own and have full control and exclusivity i think.

    this seems to tie in with the apparent aim of pyc, which seems to be find a large buyer and go out with a bang. Seems as you say myc targetting is too far down the track still for someone to invest big cash taking out both imyc and fpp's required to make it work. Hopefully they can find interest in one of the other areas. Interesting reading more this morning in news about chinese gene editing hiv immune babies and how it may have been government backed. Crispr and all that tech involved it seems. obviously again someone can already get into cells, hope were not one step behind again.
    Last edited by andrewk65: 06/03/19
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
-0.001(1.20%)
Mkt cap ! $347.0M
Open High Low Value Volume
8.3¢ 8.3¢ 8.2¢ $141.0K 1.710M

Buyers (Bids)

No. Vol. Price($)
1 200000 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 786717 1
View Market Depth
Last trade - 12.59pm 29/03/2024 (20 minute delay) ?
Last
8.2¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
8.2¢ 8.2¢ 8.2¢ 78200
Last updated 12.28pm 29/03/2024 ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.